Researchers at the University of Nottingham developed a modular platform for RNA delivery using supramolecular chemistry. This content is an AI-generated, fully rewritten summary based on a published ...
Corporate compliance isn’t just about avoiding fines; it’s an opportunity to shape culture, partnerships, and everyday decision-making Erik Vaessen on the costs, complexities, and technologies shaping ...
Moderna has announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized its updated COVID-19 mRNA vaccine, Spikevax®, targeting the SARS-CoV-2 LP.8.1 variant, for ...
Cell lysis is often seen as just another step in the upstream workflow for gene therapy production, but it’s anything but routine. This moment of breaking open cells determines not only how much ...
We are all watching the rise of oral, small molecule GLP-1 receptor agonists with justified interest. The promising phase III results of Eli Lilly’s orforglipron has set the pace, and others are ...
Pharmaceutical formulation is undergoing a quiet revolution, and most of the industry has not caught up yet. We are no longer bound by trial-and-error, or month-long iteration cycles. Thanks to ...
Scientists worldwide have condemned suggestions from Donald Trump that Tylenol is a cause of autism. The FDA has said it is initiating a label change for acetaminophen products to reflect an ...
Clinical development has always been a complex process, requiring various stakeholders including pharmaceutical and biotech companies, patient groups, clinical research organizations (CROs) and ...
The path from preclinical research to API drug commercialization is fraught with risk and complexity, with thousands of compounds narrowing down to a single drug suitable for patient use. The intense ...
AstraZeneca is expanding its cell therapy footprint in China with plans for a commercial manufacturing and supply base in Shanghai, alongside a new innovation center focused on cell therapy R&D and ...
For centuries, healers across Africa have relied on medicinal plants to treat everything from infections to chronic conditions. Their knowledge, passed down through generations, remains central to ...
An off-the-shelf CAR-T cell therapy developed by researchers at WashU Medicine has been granted FDA Breakthrough Therapy designation for relapsed or refractory T-cell acute lymphoblastic leukemia and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results